# How Do Payers and Providers Calculate Connected Care ROI?

hcco.app · September 28, 2026

> What Connected Care ROI Actually Measures Connected care ROI is the measurable financial effect of using connected devices, remote monitoring, shared...

## What Connected Care ROI Actually Measures

Connected care ROI is the measurable financial effect of using connected devices, remote monitoring, shared records, and coordinated interventions to change healthcare outcomes or operating performance. It should not be confused with a technology return-on-investment calculation based only on software savings. A connected care program may create value by reducing avoidable admissions, shorteninglengths of stay, lowering readmissions, improving medication adherence, reducing duplicated testing, enabling earlier discharge, or helping scarce clinical teams manage higher-risk patients. Revenue growth is another possible benefit, but it is harder to attribute and should be reported separately from cost reduction. For payers and providers, the central question is whether the verified health and operational gains exceed implementation, subscription, staffing, device, integration, training, maintenance, and change-management costs over a defined period.

**Also worth reading:** [How Do Healthcare Cost-Containment Platforms Work for Payers and Providers?](https://hcco.app/knowledge/how_do_healthcare_cost-containment_platforms_work_for_payers_and_providers.php) · [How Do Healthcare Payers Calculate Digital ROI in 2026?](https://hcco.app/knowledge/how_do_healthcare_payers_calculate_digital_roi_in_2026.php) · [How Should Payers and Providers Measure Prior Authorization Performance in 2026?](https://hcco.app/knowledge/how_should_payers_and_providers_measure_prior_authorization_performance_in_2026-3.php)

The calculation should use a comparison group or a credible historical baseline whenever possible. Return on investment equals net benefit divided by total program cost, multiplied by 100; for example, a program costing $1.2 million that produces $1.8 million in verified benefits has an ROI of 50%. Net benefit is benefits minus all attributable costs, while payback is the time required for cumulative benefits to recover those costs. Cost per patient, cost per member, and cost per episode are usually more useful than one organization-wide percentage because organizations serve different populations and risk levels. Any credible business case should also state its measurement period, included costs, attribution method, data sources, confidence range, and owner rather than presenting a vendor-generated estimate as realized savings.

## The Cost and Benefit Equations

A practical connected care ROI model divides benefits into medical cost changes, operating efficiency, avoided capital or facility spending, and financial outcomes. Medical cost changes might include reduced emergency department visits, inpatient admissions, readmissions, ambulance transports, or total cost of care; operating efficiency might include reduced call handling time, faster prior authorization, fewer manual chart reviews, and lower device-support costs. Benefits must be adjusted for differences in disease severity, member churn, coding practice, and utilization trends between the intervention and comparison groups. For a provider, a reduction in occupancy can create value only if staffing, capacity, or contract expense actually changes, while a payer should verify claims-level changes after claims completion and run-out.

Not every improved outcome belongs in the ROI equation. Clinical quality, patient experience, clinician satisfaction, access, and adherence may be strategic benefits, but they become financial benefits only when linked to a defensible economic mechanism. For example, improved patient experience may support retention or acquisition, but attributing a specific revenue change to a monitoring program is difficult. Medication adherence could reduce medical utilization, yet the program should count only the portion supported by credible causal evidence. A cautious model presents verified financial return, probable financial return, and unmonetized benefits separately. This prevents quality improvements from being assigned an invented dollar value simply to make the investment appear successful.

## Building a Credible Business Case

Start by defining one narrow use case, such as heart-failure remote monitoring, post-discharge transitional care, or centralized chronic disease management. Identify the eligible population, intervention, comparison population, start date, and follow-up period; broad programs covering several diseases should be divided into cohorts because their economics differ. Collect at least 12 months of baseline data when available, and note whether seasonality, a new payment contract, or a coding change could distort utilization figures. High-risk populations may appear to generate larger gross savings, but they can also cost more to monitor and may have worse outcomes for reasons unrelated to the technology.

The next step is to calculate net benefits after a claims run-out period, which may range from roughly 60 to 180 days depending on the payer and service setting. Review medical claims, encounter records, staffing schedules, travel time, equipment loss, and patient-level engagement metrics. Use an intent-to-treat approach when evaluating all eligible patients, even if some do not consistently use the device, because this reflects operational reality; report the per-protocol result separately rather than replacing the full-population result. A 20% reduction in readmissions among 500 patients with a $15,000 average avoidable cost would imply up to $1.5 million in gross medical savings, but that figure still requires adjustment for regression to the mean and differences between groups.

## Comparing Connected Care Delivery Models

There is no single connected care model that wins every comparison. A fully managed service can reduce implementation burden but limit control over workflows and data. A software platform offers greater configuration and integration flexibility but requires internal clinical, technical, and administrative resources. Remote patient monitoring is suited to patients who can operate a device and respond to alerts, whereas care-team communication tools are better for coordination, education, and exception management. Hybrid programs often combine digital monitoring with human outreach because automation alone may miss worsening symptoms or create alert fatigue.

| Feature | Platform-led connected care | Managed monitoring service | Basic digital engagement tools |
| --- | --- | --- | --- |
| Upfront effort | Moderate to high | Lower for the client | Low |
| Clinical workflow control | High | Moderate | Low to moderate |
| Typical staffing burden | Integration and operations team | Vendor-supplied clinical team | Existing care team |
| Best operational fit | Multiple sites and complex EHR workflows | Limited teams needing rapid deployment | Low-risk cohorts and simple education |
| Cost structure | Subscription, integration, devices, and internal labor | Subscription or per-patient fees plus implementation | Subscription, messaging, and training |
| Main risk | Underused platform and integration debt | Dependence on vendor staffing and data quality | Low engagement and limited clinical effect |

The table is a decision aid, not a vendor ranking. Cost-effectiveness depends on patient volume, clinical pathways, existing infrastructure, and whether the objective is utilization reduction, workflow improvement, access expansion, or patient support. Organizations should also compare the status quo because the relevant alternative is frequently not another digital product but continued manual care. The strongest option is the one that produces measurable change within the organization’s capacity, not necessarily the one with the largest number of connected devices or dashboards.

## Pricing and Budget Expectations

Connected care pricing is usually negotiated rather than standardized. A buyer may encounter per-patient monthly fees, per-enrolled-member fees, annual platform licenses, implementation charges, device and connectivity fees, clinical staffing minimums, integration fees, and separate analytics or security charges. Managed programs can appear inexpensive when compared with building an internal team, but per-patient pricing may become costly if enrollment remains high and engagement is low. A platform with a fixed annual license may be economical at scale but carry substantial internal implementation costs. Because actual contract terms are private, any planning figure should be labeled as a scenario rather than a market price.

For an initial model, include recurring technology fees, devices, connectivity, support, training, clinical labor, interface work, cybersecurity review, and a contingency reserve of about 10% to 20% of implementation cost. Model low, expected, and high enrollment because fewer active patients can reduce both benefit and monitoring expense, while nonresponders still consume outreach capacity. Sensible evaluation thresholds might be a positive ROI within 24 months for a mature program and a 10% reduction in the targeted utilization event, but thresholds must be adjusted for baseline risk and capital constraints. A program with a three-year return may still be appropriate for preventive care even if it does not meet a 12-month corporate hurdle.

## Common Measurement Mistakes

One of the most frequent errors is comparing post-program patients with a historical period that had different utilization or pricing. Another is claiming gross avoided cost as savings without accounting for intervention expense, displaced services, or services shifted to another site. A shift from inpatient care to outpatient treatment may improve the patient experience without reducing total cost, while a reduction in emergency visits might lead to later admissions that appear only after the initial measurement window. For this reason, the model should report gross impact, attributable net savings, operating impact, and unmeasured effects separately.

Vendors may also define ROI using list-price assumptions, short follow-up windows, or projections that assume every enrolled patient participates. Alert volume, login rates, and satisfaction scores are useful process indicators but are not financial outcomes. Another mistake is failing to account for patient churn, which can interrupt care and make a program look ineffective even when short-term engagement is strong. Finally, organizations should not infer causality from a dashboard alone; a controlled rollout, stepped-wedge design, matched comparison cohort, or statistical adjustment can provide stronger evidence. The level of rigor should match the size of the investment and the confidence required before scaling.

## When to Act, Pilot, or Stop

Act quickly when a documented operational problem has measurable economics, a defined patient cohort, reliable baseline data, and a workflow that already has clinical ownership. For example, a health system repeatedly managing high-risk discharges may have enough addressable cost to justify a 90-day or six-month pilot with a clearly defined primary endpoint. Payers may act earlier when a contract or quality program has already identified avoidable utilization and the organization can access timely claims data. Technology readiness also matters: stable EHR interfaces, clear escalation procedures, device support, privacy review, and staff time are stronger adoption conditions than a polished demonstration.

Pilot rather than deploy broadly when baseline utilization is unstable, the intervention is not standardized, or the evidence for the target population is weak. A pilot should include a comparison group where feasible, a pre-registered cost and utilization measure, and a decision date. Stop or redesign a program if it produces no meaningful data or workflow change after two well-executed evaluation cycles, requires unsustainable staffing, or creates safety and alert-fatigue concerns. Do not stop solely because enrollment is below an arbitrary vendor benchmark; examine whether the issue is patient fit, onboarding, device reliability, clinical workflow, or follow-up. A connected care program that increases clinician workload without improving outcomes is not a good investment regardless of its engagement metrics.

## Turning Results into an Executive Decision

The executive decision should distinguish realized return from forecast return and include uncertainty. A useful scorecard includes total cost, verified net benefit, ROI, payback period, avoided utilization, active engagement, alert resolution time, patient access, and adverse events. A results-based contract can align some vendor incentives, but buyers should specify how benefits are measured, who owns the data, what happens when enrollment changes, and whether fees are contingent on independently verified outcomes. If no outcome is achieved, a pilot may still generate organizational learning, but learning should not be converted into a claimed financial return.

By September 2026, connected care evaluation should also account for interoperability, cybersecurity, responsible AI use, and the operational burden of supporting newer smart-room and personalized-care technologies. Those requirements can increase cost, but they are not optional for regulated healthcare organizations. The most defensible conclusion is therefore conditional: connected care can produce positive ROI when it changes a costly workflow, reaches the intended patients, and is evaluated against real-world counterfactuals. It is not automatically profitable merely because it is innovative, personalized, or connected. Before expansion, request the underlying cost and utilization data, document attribution rules, and require a repeatable measurement process that the payer or provider can audit without relying on a vendor’s presentation.

## Quick answers

### What is a good connected care ROI target?

Many organizations use a positive 12- or 24-month ROI target, but no percentage is universally valid. The threshold should reflect baseline cost, clinical evidence, capital constraints, and how quickly the organization can measure utilization and financial outcomes.

### Is a reduction in hospital readmissions always a cost saving?

No. It may reduce avoidable medical expense, but savings are not realized if the program costs more, care is shifted to another setting, or the comparison population differs in risk. Claims run-out and a credible comparison group are needed before counting the reduction as net benefit.

### How long should a connected care pilot run?

A three- to six-month pilot can test operations and early utilization, but a full financial evaluation may require 12 months or more, including claims run-out. The appropriate duration depends on the disease, the primary outcome, enrollment speed, and seasonality.

### Should connected care software be priced per patient or per organization?

Both models can be appropriate. Per-patient pricing is straightforward for defined cohorts, while organization-wide licensing may be better for multi-site deployments; buyers should compare total cost after adding staffing, devices, integration, and support.

### What is the most important KPI besides ROI?

There is no single substitute for ROI, but the program should track clinical or operational outcomes such as avoidable admissions, time to intervention, alert resolution, and patient access. These measures explain why financial performance changed and reveal whether the program is functioning as intended.

Canonical: https://hcco.app/knowledge/how_do_payers_and_providers_calculate_connected_care_roi.php
Markdown: https://hcco.app/knowledge/how_do_payers_and_providers_calculate_connected_care_roi.php/index.md